Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)

• Type: Another Publication in an International Scientific Journal
• Date: 2011

Authors

Souto, SB (Author) Other; Souto, EB (Author) Other; Braga, DC (Author) Other; Medina, JL (Author) Other

Journal

Title: European Journal of Clinical Pharmacology

Vol. 67

Pages: 653-661

ISSN: 0031-6970

Publisher: Springer Nature

Indexing

ISI Web of Knowledge - 20 Citations

Scopus - 23 Citations

Other information

Authenticus ID: P-002-Q45

DOI: 10.1007/s00228-011-1038-z

Abstract (EN): The urgent need to treat type 2 diabetes mellitus (T2DM), which is currently reaching epidemic proportions, has been a major focus of healthcare systems and policy makers worldwide. Pharmacological treatment and lifestyle interventions together with the control of cardiovascular risk factors are the main strategies to prevent or delay the onset of T2DM. The present review discusses the state of the art knowledge of effective therapeutic approaches (metformin, thiazolidinediones, nateglinides, alpha-glucosidase inhibitors, incretin-based and angiotensin-based therapies, weight reducers, statins, fibric acid derivatives), including surgery, and identifies the major lifestyle changes for specific target groups.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 9